atazanavir sulfate has been researched along with rifampin in 7 studies
Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (rifampin) | Trials (rifampin) | Recent Studies (post-2010) (rifampin) |
---|---|---|---|---|---|
1,102 | 246 | 590 | 20,468 | 1,499 | 6,552 |
Protein | Taxonomy | atazanavir sulfate (IC50) | rifampin (IC50) |
---|---|---|---|
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.949 | |
Caspase-1 | Homo sapiens (human) | 8.319 | |
Alpha-synuclein | Homo sapiens (human) | 7.1 | |
Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 0.03 | |
DNA-directed RNA polymerase subunit beta | Mycobacterium tuberculosis H37Rv | 0.01 | |
Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.5 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Agarwala, S; Been-Tiktak, A; Bertz, R; Burger, DM; Child, M; Wang, Y | 1 |
Blanco, JL; Gatell, JM; López-Púa, Y; Mallolas, J; Martínez, E; Nomdedeu, M; Sarasa, M; Soriano, A | 1 |
Acosta, EP; Agarwala, S; Alston-Smith, B; Bertz, R; Child, M; Gerber, JG; Haas, DW; Hosey, L; Kendall, MA; Koletar, SL; Zolopa, AR | 1 |
Bendayan, M; Bendayan, R; Chan, GN; Couraud, PO; Ramaswamy, M; Romero, IA; Ronaldson, PT; Weksler, B; Zastre, JA | 1 |
Acosta, EP; Alston-Smith, B; Bertz, R; Child, MJ; Gerber, JG; Haas, DW; Hosey, L; Kendall, MA; Koletar, SL; Laughlin, L; Suckow, C; Zolopa, AR | 1 |
Bow, DA; Chiou, WJ; de Morais, SM; Kikuchi, R; Li, X; Voorman, RL | 1 |
Bunglawala, F; Cottura, N; Denti, P; Fabrega, F; Howarth, A; Kinvig, H; Lloyd, A; Montanha, MC; Siccardi, M; Waitt, C | 1 |
2 trial(s) available for atazanavir sulfate and rifampin
Article | Year |
---|---|
Effect of rifampin on steady-state pharmacokinetics of atazanavir with ritonavir in healthy volunteers.
Topics: Anti-HIV Agents; Area Under Curve; Atazanavir Sulfate; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Oligopeptides; Pyridines; Rifampin; Ritonavir | 2006 |
Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir.
Topics: Adult; Antitubercular Agents; Atazanavir Sulfate; Female; Gastrointestinal Tract; HIV Protease Inhibitors; Humans; Liver; Male; Oligopeptides; Pyridines; Rifampin; Ritonavir | 2009 |
5 other study(ies) available for atazanavir sulfate and rifampin
Article | Year |
---|---|
Pharmacokinetic interaction between rifampicin and ritonavir-boosted atazanavir in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Area Under Curve; Atazanavir Sulfate; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Drug Therapy, Combination; Female; HIV Protease Inhibitors; Humans; Male; Oligopeptides; Prospective Studies; Pyridines; Rifampin; Ritonavir; Tuberculosis | 2007 |
Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.
Topics: Adolescent; Adult; Anti-HIV Agents; Antitubercular Agents; Area Under Curve; Atazanavir Sulfate; Biotransformation; Drug Interactions; Female; Half-Life; HIV Infections; Humans; Male; Middle Aged; Oligopeptides; Pyridines; Rifampin; Tuberculosis | 2007 |
Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line.
Topics: Atazanavir Sulfate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain; Cell Line; Cyclosporins; Diphosphonates; Endothelium, Vascular; HIV Protease Inhibitors; Humans; Microvessels; Oligopeptides; Propionates; Pyridines; Quinolines; Rifampin; Ritonavir; Tritium; Up-Regulation | 2009 |
In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia.
Topics: Antirheumatic Agents; Atazanavir Sulfate; Bilirubin; Carbamates; Cyclosporine; Furans; Glucuronosyltransferase; HIV Protease Inhibitors; Hyperbilirubinemia; In Vitro Techniques; Indinavir; Liver-Specific Organic Anion Transporter 1; Oligopeptides; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Pyridines; Rifampin; Rifamycins; Saquinavir; Solute Carrier Organic Anion Transporter Family Member 1B3; Sulfonamides | 2014 |
Predicting Drug-Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling.
Topics: Anti-HIV Agents; Atazanavir Sulfate; Drug Interactions; HIV Infections; HIV Protease Inhibitors; Humans; Rifampin; Ritonavir | 2022 |